Patent Assignment
Reel/Frame 067168/0238
Assignment of Assignor's Interest
Recorded: 2024-04-19
Pages: 5
Assignor
SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Executed: 2024-03-12
Assignee
HIKMA PHARMACEUTICALS USA INC.
200 CONNELL DRIVE, 4TH FLOOR, BERKELEY HEIGHTS, NEW JERSEY, 07922
Covered Properties
(3)
Pharmaceutical Compositions of Tofacitinib for Oral Administration
Pharmaceutical Compositions of Tofacitinib for Oral Administration
Pharmaceutical Compositions of Tofacitinib for Oral Administration
Application:
18/598,526 →
Publication:
US 2024/0207278
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 16, 2022
From: DUBE, SUSHANT OMPRAKASH; KULKARNI, PURUSHOTTAM DATTATRAYA; PATTEWAR, PURUSHOTTAM SAKHAHARI; PILLAI, SUMITRA ASHOKKUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 059025/0876 →
Security Interest
Sep 27, 2023
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065045/0560 →
Partial Termination and Release of Security Interest in Patents
Apr 3, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 066987/0120 →
Release of Security Interest
Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →